Literature DB >> 11714636

Regulation of extracellular signal-regulated kinase activity by p120 RasGAP does not involve its pleckstrin homology or calcium-dependent lipid binding domains but does require these domains to regulate cell proliferation.

J A Koehler1, M F Moran.   

Abstract

The gene encoding for p120 RasGAP, has been disrupted in mice (M. Henkemeyer et al., Nature (Lond.), 377: 695-701, 1995). In this study, using fibroblasts derived from these mouse embryos (Gap-/-; P. van der Geer et al., Mol. Cell Biol., 17: 1840-1847, 1997), we demonstrate that mitogen-activated protein kinase (MAPK) activation is prolonged after epidermal growth factor (EGF), but not lysophosphatidic acid, stimulation as compared with wild-type cells. Furthermore, these cells exhibited a moderate increase in their proliferative rate and saturation density, as well as a limited ability to form colonies in soft agar. Stable cell lines expressing full-length p120GAP not only restored the ability to down-regulate MAPK after EGF stimulation but also lowered their saturation densities. Similarly, expression of p120GAP, missing either its pleckstrin homology (PH) or its calcium-dependent lipid binding (CaLB)/C2 domain, restored MAPK down-regulation and retained the ability to associate with p190 RhoGAP and to be phosphorylated by v-src but exhibited higher saturation densities similar to Gap-/- cells. Our results, therefore, suggest that p120GAP functions not only by down-regulating the Ras/MAPK pathway after growth factor stimulation but is also important in regulating cell proliferation that involves its PH and CaLB domains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714636

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  8 in total

1.  Integrin signaling through Arg activates p190RhoGAP by promoting its binding to p120RasGAP and recruitment to the membrane.

Authors:  William D Bradley; Samuel E Hernández; Jeffrey Settleman; Anthony J Koleske
Journal:  Mol Biol Cell       Date:  2006-09-13       Impact factor: 4.138

2.  The human papillomavirus E7 proteins associate with p190RhoGAP and alter its function.

Authors:  Biljana Todorovic; Anthony C Nichols; Jennifer M Chitilian; Michael P Myers; Trevor G Shepherd; Sarah J Parsons; John W Barrett; Lawrence Banks; Joe S Mymryk
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  Differential Regulation of RasGAPs in Cancer.

Authors:  Thomas Grewal; Meryem Koese; Francesc Tebar; Carlos Enrich
Journal:  Genes Cancer       Date:  2011-03

4.  Expression changes and bioinformatic analysis of Wallerian degeneration after sciatic nerve injury in rat.

Authors:  Dengbing Yao; Meiyuan Li; Dingding Shen; Fei Ding; Shibi Lu; Qing Zhao; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2013-05-23       Impact factor: 5.203

5.  Gene expression profiling of the rat sciatic nerve in early Wallerian degeneration after injury.

Authors:  Dengbing Yao; Meiyuan Li; Dingding Shen; Fei Ding; Shibi Lu; Qin Zhao; Xiaosong Gu
Journal:  Neural Regen Res       Date:  2012-06-15       Impact factor: 5.135

6.  The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.

Authors:  Yan Cui; Susann Groth; Scott Troutman; Annemarie Carlstedt; Tobias Sperka; Lars Björn Riecken; Joseph L Kissil; Hongchuan Jin; Helen Morrison
Journal:  Oncogene       Date:  2019-07-16       Impact factor: 9.867

7.  Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1.

Authors:  Oliver A Kent; Joshua T Mendell; Robert Rottapel
Journal:  Mol Cancer Res       Date:  2016-01-08       Impact factor: 5.852

8.  p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line.

Authors:  Shawna L Organ; Josephine Hai; Nikolina Radulovich; Christopher B Marshall; Lisa Leung; Takehiko Sasazuki; Senji Shirasawa; Chang-Qi Zhu; Roya Navab; Mitsuhiko Ikura; Ming-Sound Tsao
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.